EarningsQ2 2024 Earnings Report

Rohto Pharmaceutical Co (4527N) Q2 2024 Earnings Report

0 Followers

MX:4527N Q2 2024 EPS Results

Actual EPS$2.21

Consensus EPS$3.99

Beat/MissMissed by -$1.77

One Year Ago EPS$3.74

Actual Revenue$8.04B

Expected Revenue$8.08B

Beat/MissMissed by -$33.70M

YoY Revenue Growth+6.04%

QuarterQ2 2024

Date11/13/2024

TimeTBA

Conference CallWednesday, November 13, 2024

MX:4527N Upcoming Earnings

Rohto Pharmaceutical Co's next earnings date is estimated for November 12, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 12, 2026	2026 (Q2)	3.73 / -	2.96	―
Aug 06, 2026	2026 (Q1)	4.53 / 5.36	5.923	-9.50% (-0.56)
May 13, 2026	2025 (Q4)	3.45 / 3.00	3.113	-3.54% (-0.11)
Feb 12, 2026	2025 (Q3)	5.02 / 5.35	5.923	-9.71% (-0.58)
Nov 13, 2025	2025 (Q2)	2.84 / 2.96	2.213	33.76% (+0.75)
Aug 06, 2025	2025 (Q1)	- / 5.92	4.227	40.10% (+1.70)
May 13, 2025	2024 (Q4)	2.84 / 3.11	2.382	30.69% (+0.73)
Feb 12, 2025	2024 (Q3)	5.58 / 5.92	4.766	24.26% (+1.16)
Nov 13, 2024	2024 (Q2)	3.99 / 2.21	3.74	-40.83% (-1.53)
Aug 07, 2024	2024 (Q1)	4.54 / 4.23	4.531	-6.70% (-0.30)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed